SNY - Sanofi

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
128.58B
Enterprise Value 3
128.3B
Trailing P/E
26.41
Forward P/E 1
14.72
PEG Ratio (5 yr expected) 1
2.08
Price/Sales (ttm)
N/A
Price/Book (mrq)
1.95
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.49
52-Week Change 323.38%
S&P500 52-Week Change 325.98%
52 Week High 351.84
52 Week Low 340.00
50-Day Moving Average 349.68
200-Day Moving Average 345.55

Share Statistics

Avg Vol (3 month) 31.8M
Avg Vol (10 day) 31.31M
Shares Outstanding 52.5B
Float 2.23B
% Held by Insiders 10.00%
% Held by Institutions 17.64%
Shares Short (Dec 30, 2019) 42.05M
Short Ratio (Dec 30, 2019) 41.48
Short % of Float (Dec 30, 2019) 4N/A
Short % of Shares Outstanding (Dec 30, 2019) 40.16%
Shares Short (prior month Nov 28, 2019) 42.16M

Dividends & Splits

Forward Annual Dividend Rate 41.74
Forward Annual Dividend Yield 43.39%
Trailing Annual Dividend Rate 33.53
Trailing Annual Dividend Yield 36.90%
5 Year Average Dividend Yield 43.90
Payout Ratio 4123.20%
Dividend Date 3May 30, 2019
Ex-Dividend Date 4May 06, 2019
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in EUR.

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 8.31%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)1.80%
Gross Profit (ttm)24.36B
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)1.94
Quarterly Earnings Growth (yoy)-22.30%

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)47.23
Current Ratio (mrq)N/A
Book Value Per Share (mrq)26.25

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A